Hercules Capital, Inc. (NYSE:HTGC) Shares Purchased by Muzinich & Co. Inc.

Muzinich & Co. Inc. increased its stake in Hercules Capital, Inc. (NYSE:HTGC - Free Report) by 13.4% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 510,371 shares of the financial services provider's stock after purchasing an additional 60,375 shares during the quarter. Hercules Capital makes up 5.6% of Muzinich & Co. Inc.'s investment portfolio, making the stock its 8th largest holding. Muzinich & Co. Inc. owned approximately 0.29% of Hercules Capital worth $9,804,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in HTGC. Bank of New York Mellon Corp lifted its holdings in Hercules Capital by 67.5% in the 4th quarter. Bank of New York Mellon Corp now owns 82,380 shares of the financial services provider's stock worth $1,655,000 after purchasing an additional 33,191 shares during the last quarter. HighTower Advisors LLC increased its position in Hercules Capital by 23.8% in the 4th quarter. HighTower Advisors LLC now owns 77,276 shares of the financial services provider's stock worth $1,552,000 after buying an additional 14,841 shares during the period. Commonwealth Equity Services LLC increased its position in Hercules Capital by 1.5% in the 4th quarter. Commonwealth Equity Services LLC now owns 327,372 shares of the financial services provider's stock worth $6,577,000 after buying an additional 4,896 shares during the period. Signaturefd LLC increased its position in Hercules Capital by 86.6% in the 4th quarter. Signaturefd LLC now owns 6,634 shares of the financial services provider's stock worth $133,000 after buying an additional 3,079 shares during the period. Finally, Axxcess Wealth Management LLC increased its position in Hercules Capital by 12.3% in the 4th quarter. Axxcess Wealth Management LLC now owns 17,177 shares of the financial services provider's stock worth $345,000 after buying an additional 1,875 shares during the period. 19.69% of the stock is currently owned by institutional investors and hedge funds.

Hercules Capital Price Performance

HTGC stock traded up $0.07 during trading on Friday, hitting $19.50. The company had a trading volume of 204,799 shares, compared to its average volume of 1,214,631. The company has a fifty day moving average price of $18.06 and a two-hundred day moving average price of $18.91. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt-to-equity ratio of 0.99. The company has a market cap of $3.42 billion, a P/E ratio of 14.64 and a beta of 0.93. Hercules Capital, Inc. has a fifty-two week low of $15.65 and a fifty-two week high of $22.04.

Hercules Capital (NYSE:HTGC - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The financial services provider reported $0.45 EPS for the quarter, missing the consensus estimate of $0.46 by ($0.01). The company had revenue of $102.10 million during the quarter, compared to analyst estimates of $125.43 million. Hercules Capital had a net margin of 45.23% and a return on equity of 16.84%. Hercules Capital's quarterly revenue was down 1.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.50 EPS. Equities research analysts expect that Hercules Capital, Inc. will post 1.96 earnings per share for the current fiscal year.

Hercules Capital Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, May 20th. Shareholders of record on Tuesday, May 13th were paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 8.21%. The ex-dividend date of this dividend was Tuesday, May 13th. Hercules Capital's dividend payout ratio is currently 120.30%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on HTGC shares. UBS Group lifted their price target on Hercules Capital from $18.50 to $19.00 and gave the stock a "neutral" rating in a research report on Wednesday. Wells Fargo & Company dropped their price target on Hercules Capital from $21.00 to $19.00 and set an "overweight" rating on the stock in a research report on Monday, April 28th. Keefe, Bruyette & Woods dropped their price target on Hercules Capital from $21.50 to $20.50 and set an "outperform" rating on the stock in a research report on Tuesday, April 8th. Finally, Piper Sandler lowered their price objective on Hercules Capital from $23.00 to $20.00 and set an "overweight" rating on the stock in a research report on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, Hercules Capital currently has a consensus rating of "Moderate Buy" and a consensus target price of $20.08.

Insider Buying and Selling

In other Hercules Capital news, Director Nikos Theodosopoulos acquired 5,999 shares of Hercules Capital stock in a transaction on Thursday, May 8th. The shares were bought at an average price of $17.49 per share, with a total value of $104,922.51. Following the completion of the purchase, the director owned 11,960 shares in the company, valued at $209,180.40. This trade represents a 100.64% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 1.90% of the company's stock.

Hercules Capital Profile

Hercules Capital, Inc is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.